← CVS HEALTH Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $177.5b $184.8b $193.9b $256.8b $268.7b $292.1b $322.5b $357.8b $372.8b $402.1b
Cost of Revenue $148.7b $156.2b $156.4b $158.7b $164.0b $175.8b $196.9b $217.1b $206.3b $221.2b
Gross Profit (derived) $28.9b $28.5b $37.5b $98.1b $104.7b $116.3b $125.6b $140.7b $166.5b $180.9b
Operating Expenses $18.5b $19.0b $21.4b $33.5b $35.1b $37.1b $38.2b $39.8b $41.6b $45.0b
Total operating costs $167.2b $175.2b $190.6b $244.8b $254.8b $278.9b $314.7b $344.0b $364.3b $397.4b
Operating Income (Loss) $10.3b $9.5b $4.0b $12.0b $13.9b $13.2b $7.7b $13.7b $8.5b $4.7b
Additional Financial Items
Depreciation, Depletion and Amortization, Nonproduction $2.5b $2.5b — — — — — — — —
Amortization of Intangible Assets $795.0m $817.0m $1.0b $2.4b $2.3b $2.3b $1.8b $1.9b $2.0b $2.0b
Gain (Loss) Related to Litigation Settlement — — — — — — ($5.8b) $0 ($100.0m) —
Goodwill, Impairment Loss $0 $181.0m $6.1b $0 $0 $431.0m $0 $0 $0 $5.7b
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — — — — $1.3b
Income (Loss) from Continuing Operations, Per Basic Share $5 $6 ($1) $5 $5 $6 $3 — — —
Income (Loss) from Continuing Operations, Per Diluted Share $5 $6 ($1) $5 $5 $6 $3 — — —
Investment Income, Interest $20.0m $21.0m — — — — — — — —
Realized Investment Gains (Losses) — — $3.0m $199.0m $52.0m $176.0m ($320.0m) ($497.0m) $117.0m ($44.0m)
Premiums — $3.6b $8.2b $63.1b $69.4b $76.1b $85.3b $99.2b $122.9b $134.8b
Goodwill impairment $0 $181.0m $6.1b $0 $0 $431.0m $0 $0 $0 $5.7b
Restructuring charges ($1.0m) ($8.0m) $0 $0 ($9.0m) $0 $0 $507.0m $1.2b $0
Loss on assets held for sale — — — — $0 $0 $2.5b $349.0m $0 $0
Gain on early extinguishment of debt $643.0m $0 $0 $79.0m $1.4b $452.0m $0 $0 ($491.0m) $0
Gain on deconsolidation of subsidiary — — — — — — — $0 $0 $483.0m
Other income $28.0m $208.0m ($4.0m) ($124.0m) ($206.0m) ($182.0m) ($169.0m) ($88.0m) ($99.0m) $112.0m
Income tax provision $3.3b $1.6b $2.0b $2.4b $2.6b $2.5b $1.5b $2.8b $1.6b $408.0m
Net (income) loss attributable to noncontrolling interests ($2.0m) ($1.0m) $2.0m $3.0m ($13.0m) $12.0m ($16.0m) ($24.0m) $28.0m $40.0m
Basic (in shares) $1.1b $1.0b $1.0b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b
Diluted (in shares) $1.1b $1.0b $1.0b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8.6b $8.3b $1.4b $9.0b $9.8b $10.4b $5.6b $11.2b $6.1b $2.1b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $5.3b $6.6b ($597.0m) $6.6b $7.2b $7.9b $4.1b — — —
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $5.3b $6.6b ($596.0m) $6.6b $7.2b $7.9b $4.2b — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($1.0m) ($8.0m) $0 $0 ($9.0m) $0 $0 $507.0m $1.2b $0
Investment Income, Net $20.0m $21.0m $660.0m $1.0b $798.0m $1.2b $838.0m $1.2b $2.2b $2.2b
Net Investment Income $20.0m $21.0m $660.0m $1.0b $798.0m $1.2b $838.0m $1.2b $2.2b $2.2b
Income before income tax provision $8.6b $8.3b $1.4b $9.0b $9.8b $10.4b $5.6b $11.2b $6.1b $2.1b
Net Income (Loss) Attributable to Parent $5.3b $6.6b ($594.0m) $6.6b $7.2b $7.9b $4.1b $8.3b $4.6b $1.8b
Net Income (Loss) Available to Common Stockholders, Basic $5.3b $6.6b ($594.0m) $6.6b $7.2b $7.9b $4.1b $8.3b $4.6b $1.8b
Net Income (Loss) Attributable to Noncontrolling Interest $2.0m $1.0m ($2.0m) ($3.0m) $13.0m ($12.0m) $16.0m $24.0m ($28.0m) ($40.0m)
Earnings Per Share, Basic $4.93 $6.47 ($0.57) $5.10 $5.48 $6.00 $3.16 $6.49 $3.67 $1.40
Earnings Per Share, Diluted $4.90 $6.44 ($0.57) $5.08 $5.46 $5.95 $3.14 $6.47 $3.66 $1.39
Common Stock, Dividends, Per Share, Declared $1.70 $2.00 $2.00 $2.00 $2.00 $2.00 $2.20 $2.42 $2.66 $2.66
Weighted Average Number of Shares Outstanding, Basic 1.1b 1.0b 1.0b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b
Weighted Average Number of Shares Outstanding, Diluted 1.1b 1.0b 1.0b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b
Other Nonoperating Income (Expense) — — $4.0m $124.0m $206.0m $182.0m $169.0m $88.0m $99.0m $112.0m
Deferred Policy Acquisition Costs, Amortization Expense — — — — — — — $265.0m $299.0m $346.0m
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims — — — — — — — $86.0b $114.8b $125.3b
Other Cost and Expense, Operating $18.5b $19.0b $21.4b $33.5b $35.1b $37.1b $38.2b $39.8b $41.6b $45.0b
Cost of products sold $146.5b $153.4b $156.4b $158.7b $164.0b $175.8b $196.9b $217.1b $206.3b $221.2b
Health care costs $2.2b $2.8b $6.6b — — $64.2b $71.1b $86.2b $115.1b $125.5b
Interest Expense $1.1b $1.1b $2.6b $3.0b $2.9b $2.5b $2.3b $2.7b $3.0b ($3.1b)
Interest Expense (non-operating) — — — — — — — — $3.0b $3.1b
Current Income Tax Expense (Benefit) $3.3b $3.1b $2.0b $3.0b $3.1b $3.0b $3.5b $3.5b $2.1b $306.0m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — ($187.0m) $0 $0 — — — — — —
Interest Income (Expense), Net ($1.1b) ($1.0b) — $0 $0 — — — — —
Income Tax Expense (Benefit) $3.3b $1.6b $2.0b $2.4b $2.6b $2.5b $1.5b $2.8b $1.6b $408.0m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.